rs1721082

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_019851.3(FGF20):​c.*449T>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.695 in 151,650 control chromosomes in the GnomAD database, including 37,848 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.69 ( 37789 hom., cov: 30)
Exomes 𝑓: 0.68 ( 59 hom. )

Consequence

FGF20
NM_019851.3 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.127

Publications

2 publications found
Variant links:
Genes affected
FGF20 (HGNC:3677): (fibroblast growth factor 20) The protein encoded by this gene is a member of the fibroblast growth factor family. The fibroblast growth factors possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. This gene product is a secreted neurotrophic factor but lacks a typical signal peptide. It is expressed in normal brain, particularly the cerebellum, and may regulate central nervous system development and function. Homodimerization of this protein was shown to regulate its receptor binding activity and concentration gradient in the extracellular matrix. Genetic variations of this gene have been associated with Parkinson disease susceptibility. [provided by RefSeq, Oct 2009]
FGF20 Gene-Disease associations (from GenCC):
  • bilateral renal agenesis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • renal hypodysplasia/aplasia 2
    Inheritance: AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.779 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FGF20NM_019851.3 linkc.*449T>A 3_prime_UTR_variant Exon 3 of 3 ENST00000180166.6 NP_062825.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FGF20ENST00000180166.6 linkc.*449T>A 3_prime_UTR_variant Exon 3 of 3 1 NM_019851.3 ENSP00000180166.5

Frequencies

GnomAD3 genomes
AF:
0.695
AC:
105126
AN:
151316
Hom.:
37774
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.513
Gnomad AMI
AF:
0.840
Gnomad AMR
AF:
0.684
Gnomad ASJ
AF:
0.820
Gnomad EAS
AF:
0.511
Gnomad SAS
AF:
0.723
Gnomad FIN
AF:
0.866
Gnomad MID
AF:
0.737
Gnomad NFE
AF:
0.785
Gnomad OTH
AF:
0.702
GnomAD4 exome
AF:
0.680
AC:
151
AN:
222
Hom.:
59
Cov.:
0
AF XY:
0.650
AC XY:
78
AN XY:
120
show subpopulations
African (AFR)
AF:
0.333
AC:
2
AN:
6
American (AMR)
AF:
0.500
AC:
7
AN:
14
Ashkenazi Jewish (ASJ)
AF:
0.500
AC:
1
AN:
2
East Asian (EAS)
AF:
0.333
AC:
2
AN:
6
South Asian (SAS)
AF:
0.667
AC:
4
AN:
6
European-Finnish (FIN)
AF:
0.875
AC:
7
AN:
8
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.724
AC:
126
AN:
174
Other (OTH)
AF:
0.333
AC:
2
AN:
6
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.695
AC:
105177
AN:
151428
Hom.:
37789
Cov.:
30
AF XY:
0.699
AC XY:
51712
AN XY:
74006
show subpopulations
African (AFR)
AF:
0.514
AC:
21231
AN:
41332
American (AMR)
AF:
0.684
AC:
10403
AN:
15210
Ashkenazi Jewish (ASJ)
AF:
0.820
AC:
2843
AN:
3468
East Asian (EAS)
AF:
0.512
AC:
2641
AN:
5162
South Asian (SAS)
AF:
0.722
AC:
3471
AN:
4806
European-Finnish (FIN)
AF:
0.866
AC:
8888
AN:
10266
Middle Eastern (MID)
AF:
0.741
AC:
218
AN:
294
European-Non Finnish (NFE)
AF:
0.784
AC:
53247
AN:
67876
Other (OTH)
AF:
0.699
AC:
1469
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1495
2990
4485
5980
7475
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
820
1640
2460
3280
4100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.741
Hom.:
5325
Bravo
AF:
0.673

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.58
DANN
Benign
0.53
PhyloP100
0.13
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1721082; hg19: chr8-16850132; API